跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAN-107
首页
药物
CAN-107
CAN-107
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
LACTOBACILLUS FERMENTUM BACTERIA WITH ANTIFUNGAL ACTIVITY
US 2018249727 A1
申请人: CHR HANSEN AS
优先权: 2015
CN
US
WO
3 件公开
A PHYTOACTIVE ENCAPSULATED FORMULATION FOR NEURODEGENERATIVE DISEASES
EP 4493170 A4
申请人: GIDAA LIFE SCIENCES PVT LTD
优先权: 2022
EP
US
WO
3 件公开
Antibodies and related molecules and uses thereof
US 11566075 B2
申请人: CANCER RESEARCH TECH LTD
优先权: 2016
US
WO
3 件公开
SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES
EP 3960767 A3
申请人: NOVARTIS AG
优先权: 2014
CN
EP
2 件公开
Cardiomyocyte preparation and preparation method therefor and use thereof
US 12077781 B2
申请人: HELP STEM CELL INNOVATIONS CO LTD
优先权: 2018
US
WO
2 件公开
COMPOSITIONS COMPRISING SURFACE MODIFIED GLOBULAR NANO-PARTICLES
US 20250144039 A1
申请人: LANDA LABS 2012 LTD
优先权: 2022
US
WO
2 件公开
EP 4536755 A1
申请人: LANDA LABS 2012 LTD
优先权: 2023
EP
SECRETION SIGNAL PEPTIDE GENE DERIVED FROM BACTERIUM OF GENUS HYDROGENOPHILUS
EP 4759931 A1
申请人: UTILIZATION OF CARBON DIOXIDE INST CO LTD
优先权: 2023
EP
WO
2 件公开
CHITOSAN TEMPERATURE-SENSITIVE GEL COMPOSITION FOR TREATING OSTEOARTHRITIS AND PREPARATION METHOD THEREFOR
WO 2025261306 A1
申请人: QINGDAO ANYRULE BIOLOGICAL HEALTH TECH CO LTD
优先权: 2024
CN
WO
2 件公开
Stabilized immunogenic HBc chimer particles
US 2007015199 A1
申请人: APOVIA INC
优先权: 2003
US
2 件公开
CN 1838967 B
申请人: LORANTIS LTD
优先权: 2003
CN
HMGB1 binding nucleic acid molecule and applications thereof
US 9278108 B2
申请人: TAKENAKA HIROMI
优先权: 2009
US
2 件公开
第 1 / 9 页
上一页
下一页
药物
反馈